Target Healthcare REIT Ltd (THRL)'s decision to rebase the quarterly DPS targeted for H223 (-17% to 1.4p per quarter) established full...

Alkane Resources Ltd continues to increase its production guidance, indicating confidence in a strong close to FY23, from 62,000–70,000oz...

Wheaton Precious Metals (WPM’s) Q123 results are scheduled for 4 May. Ahead of their release, Edison Group has refined their forecasts to...

With Q423 trading slightly better than expected, discoverIE Group plc is on track to deliver FY23 underlying earnings ahead of board...

Esker Inc reported 17% y-o-y revenue growth for Q123, with 21% y-o-y growth in SaaS revenue (83% of group revenue) on an organic constant...

Basilea Pharmaceutica has announced that there will be a minor delay in the timing of its new drug application (NDA) for Zevtera...

Tetragon Financial Group Limited published its annual results on 3 March, posting a 1.0% net asset value (NAV) per share total return...

ERGOMED, a services business which includes an industry-leading suite of specialist pharmacovigilance solutions, reported FY22 results...

After the usual slower start to the year, Treatt (a global team of innovative scientists, delivering exceptional natural extracts and...

Vietnam Enterprise Investments (VEIL) is the UK’s largest and oldest listed Vietnamese equities closed-end fund. Despite Vietnam’s bright...